Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The first ever Orthopaedic Surgical Trials Day was held at the Royal College of Surgeons (RCS) this March. The objective of the day was to bring together the orthopaedic surgical research community to present current trials, intended projects and discuss issues that affect surgical trial research in this area.

The first ever Orthopaedic Surgical Trials Day was held at the Royal College of Surgeons (RCS) this March. The objective of the day was to bring together the orthopaedic surgical research community to present current trials, intended projects and discuss issues that affect surgical trial research in this area.

The workshop was  attended by both experienced and novice clinical researchers, surgeons, research nurses and the odd Channel 4 newsreader! Jon Snow gave a talk about the role media can play in promoting clinical research.

NDORMS were well represented at the event, with Head of department Professor Andrew Carr presenting on “Challenges with surgical trials” and Professor David Beard speaking about the 'Can Shoulder Arthroscopy Work?' study (CSAW); Professor Beard also highlighted other studies from the NDORMS Surgical Intervention Trials Unit (SITU) portfolio. Naomi Merritt and Cushla Cooper, from the CSAW study hosted a breakout session in collaboration with colleagues from the University of Bristol; their session focused on the perils of recruiting patients to studies and they presented work from the Qualitative Recruitment Investigation that was included in the CSAW study.

The event showed how far we have come in the world of surgical research and it was very rewarding for the SITU team to see how the increasing portfolio of orthopaedic and plastics trials in the its portfolio (UKUFF, TOPKAT, CSAW, NINJA) has helped shape current orthopaedic surgical trials research. The day also provided an excellent opportunity for the Oxford group to share their knowledge and experience with the wider orthopaedic community and the team are very much looking forward to sponsoring more of these events and, along with a strong partnership with the British Orthopaedic Association unit at York, help move orthopaedic research into the future.

The RCS day was supplemented by a Trauma and Orthopaedics trials day and Trauma Society special interest day hosted by Professor Matt Costa in Warwick. Again, Oxford had good representation with David Beard speaking on behalf of SITU.

The day was sponsored jointly by the RCS, the Oxford Surgical Intervention Trials Unit at NDORMS and the British Orthopaedic Association Orthopaedic Surgery Research Centre (York Trials Unit).

If you have any comments on the day or would like to find out more, please contact Cushla Cooper, SITU Portfolio Manager (Orthopaedics & Plastics).

Similar stories

COVID-19 vaccines shown to reduce infection by 90% in nursing homes

A new collaborative study between the Catalan Institute of Health, the Public Health Secreatariat of Catalonia, and the Centre for Statistics in Medicine, NDORMS, at the University of Oxford have confirmed that COVID-19 vaccines greatly reduce infections, hospitalisations and mortality for up to 6 months.

The Kennedy Institute completes its roof extension

Building work at the Kennedy Institute of Rheumatology has finished, providing a new third floor that houses additional meeting and collaboration space for data science and offices for the management of clinical trials.

Unlocking the secrets of the microbiome

Jethro Johnson, Deputy Director of the Oxford Centre for Microbiome Research explains how the centre is building a research community to understand the microbiome and harness its power to promote health and prevent disease.

Into the future: watching biology unfold

As part of the University of Oxford’s mission to provide its researchers with the newest state-of-the-art optical imaging equipment and as part of a strategic partnership with the Kennedy Institute of Rheumatology (KIR), the Institute of Developmental and Regenerative Medicine (IDRM), and Carl Zeiss AG (ZEISS), ZEISS has installed a ZEISS Lattice Lightsheet 7 microscope at the KIR.

New Botnar Research Institute Director starts today

Professor Jonathan Rees begins his new role as Director of the Botnar Research Institute today, taking over from Professor Andrew Carr.

Patient and public involvement in Rheumatology research – embracing the wave of change

On launching the new OPEN ARMS PPI group in Oxford, Dr. Laura Coates explored the patient and public involvement (PPI) models of three academic centres in the UK to show how it benefits researchers, clinicians, and patients alike.